Compare · head to head
Johnson & Johnson vs RadNet
Johnson & Johnson ranks higher overall — 360 rank 64 vs 14.
Johnson & Johnson leads on Quality (55 vs 28) and Safety (70 vs 21). RadNet leads on Sentiment (65 vs 47). The two are close on Value and Growth.
Ranks as of 2026-06-12 · 1–100 vs true peers. Higher is better.
| Compare | ||
|---|---|---|
| Profile | ||
| Country | USA | USA |
| Sector | Health Care | Health Care |
| Industry | Pharmaceuticals | Health Care Providers & Services |
| Size | Medium | Large |
| ISIN | US4781601046 | US7504911022 |
| Last update | 2026-04-02 | 2026-04-02 |
| History | ||
| 360 (V1) since 2023 | ||
| Ranks | ||
| 360 | 64 | 14 |
| Value | 38 | 35 |
| Quality | 55 | 28 |
| Growth | 54 | 56 |
| Safety | 70 | 21 |
| Sentiment | 47 | 65 |
| Quality details | ||
| Profitability | 69 | 29 |
| Cash Truth | 41 | 28 |
Johnson & Johnson vs NektarJohnson & Johnson vs Pfizer LimitedJohnson & Johnson vs Ocular TherapeutixJohnson & Johnson vs Intellia TherapeuticsAdd a third stock →
Full analyses: Johnson & Johnson · RadNet
Make Sense of the Ranks
Every rank runs 1–100 against true peers. Higher is always better.
360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100